Viewing Study NCT00754702


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
Study NCT ID: NCT00754702
Status: TERMINATED
Last Update Posted: 2015-09-28
First Post: 2008-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer
Sponsor: University Hospital of Crete
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module